In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, ...

Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

This week on FYI Philly, we visit the Snack Shack, the Secondhand Ranch, and a Bobby Flay favorite comes to Philly.

Changes to a key component of the Patient Driven Payment Model remain in limbo two years after they were first proposed, but federal regulators are still poised to refine the system to accommodate for ...

A research team has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease. Scientists used their tool, named Merlin, to assess 3D ...

The Oregon Health Authority is urging riders to take safety precautions when using e-scooters and e-bicycles, as new data show a sharp increase in serious injuries associated with these “micromobility ...

“Yes, doctor. My dad’s first fall was on his 65th birthday. He stood in the driveway and suddenly dropped backwards on his back. After he fell two more times, we came to the clinic.” The symptoms the ...

Advances in network science, artificial intelligence, and clinician networks may shift medical decisions from individual doctors to groups—and even AI models—at scale.

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsRobert Eno - CEO, Chief Business Officer & ...

Seeing blood in urine is often the first clue that something is wrong. For many people, noticing this symptom prompts a medical visit that can lead to ...

Insmed Incorporated ( INSM) Leerink Global Healthcare Conference 2026 March 10, 2026 8:00 AM EDT Good morning. Welcome to this fireside chat with Insmed. I'm Joe Schwartz from the biopharma equity ...